These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 33139977)

  • 21. High penetrance of acute intermittent porphyria in a Spanish founder mutation population and CYP2D6 genotype as a susceptibility factor.
    Barreda-Sánchez M; Buendía-Martínez J; Glover-López G; Carazo-Díaz C; Ballesta-Martínez MJ; López-González V; Sánchez-Soler MJ; Rodriguez-Peña L; Serrano-Antón AT; Gil-Ferrer R; Martínez-Romero MDC; Carbonell-Meseguer P; Guillén-Navarro E
    Orphanet J Rare Dis; 2019 Feb; 14(1):59. PubMed ID: 30808393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An update of clinical management of acute intermittent porphyria.
    Pischik E; Kauppinen R
    Appl Clin Genet; 2015; 8():201-14. PubMed ID: 26366103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel heterozygous mutation in the HMBS gene in a patient with acute intermittent porphyria and posterior reversible encephalopathy syndrome.
    Yang Y; Chen X; Wu H; Peng H; Sun W; He B; Yuan Z
    Mol Med Rep; 2020 Jul; 22(1):516-524. PubMed ID: 32377710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homozygous hydroxymethylbilane synthase knock-in mice provide pathogenic insights into the severe neurological impairments present in human homozygous dominant acute intermittent porphyria.
    Yasuda M; Gan L; Chen B; Yu C; Zhang J; Gama-Sosa MA; Pollak DD; Berger S; Phillips JD; Edelmann W; Desnick RJ
    Hum Mol Genet; 2019 Jun; 28(11):1755-1767. PubMed ID: 30615115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute Intermittent Porphyria Presenting with Posterior Reversible Encephalopathy Syndrome: A Rare Cause of Abdominal Pain and Seizures.
    Sarala Kumari D; Arumilli MN; Siva Kumar Reddy L; Reddy DN; Motor R
    Indian J Crit Care Med; 2020 Aug; 24(8):724-726. PubMed ID: 33024385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pilot study of mitochondrial bioenergetics in subjects with acute porphyrias.
    Dixon N; Li T; Marion B; Faust D; Dozier S; Molina A; Rudnick S; Bonkovsky HL
    Mol Genet Metab; 2019 Nov; 128(3):228-235. PubMed ID: 31153822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel mutation in the porphobilinogen deaminase gene in an extended Chinese family with acute intermittent porphyria.
    Yang J; Wang H; Yin K; Hua B; Zhu T; Zhao Y; Guo S; Yu X; Wu W; Zhou Z
    Gene; 2015 Jul; 565(2):288-90. PubMed ID: 25870942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversible splenial lesion syndrome (RESLES) due to acute intermittent porphyria with a novel mutation in the hydroxymethylbilane synthase gene.
    Yang J; Han F; Chen Q; Zhu T; Zhao Y; Yu X; Zhu H; Cao J; Li X
    Orphanet J Rare Dis; 2020 Apr; 15(1):98. PubMed ID: 32306994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenoviral-mediated expression of porphobilinogen deaminase in liver restores the metabolic defect in a mouse model of acute intermittent porphyria.
    Johansson A; Nowak G; Möller C; Blomberg P; Harper P
    Mol Ther; 2004 Aug; 10(2):337-43. PubMed ID: 15294180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correction of the biochemical defect in porphobilinogen deaminase deficient cells by non-viral gene delivery.
    Johansson A; Möller C; Harper P
    Mol Cell Biochem; 2003 Aug; 250(1-2):65-71. PubMed ID: 12962144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic strategies for acute intermittent porphyria.
    Zhao L; Wang X; Zhang X; Liu X; Ma N; Zhang Y; Zhang S
    Intractable Rare Dis Res; 2020 Nov; 9(4):205-216. PubMed ID: 33139979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HMBS gene mutations and hydroxymethylbilane synthase activity in acute intermittent porphyria: A systematic review.
    Li S; Lei JJ; Dong BX; Ren Y; Yang J
    Medicine (Baltimore); 2023 Sep; 102(39):e35144. PubMed ID: 37773850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between biochemical findings, structural and enzymatic abnormalities in mutated HMBS identified in six Israeli families with acute intermittent porphyria.
    Ulbrichova D; Schneider-Yin X; Mamet R; Saudek V; Martasek P; Minder EI; Schoenfeld N
    Blood Cells Mol Dis; 2009; 42(2):167-73. PubMed ID: 19138865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel Mutation of Hydroxymethylbilane Synthase in a Case of Acute Intermittent Porphyria Presenting with Posterior Reversible Encephalopathy Syndrome.
    Yang AL; Ma LM; Zhang HJ; Zhang JW
    J Coll Physicians Surg Pak; 2022 Dec; 32(12):SS102-SS104. PubMed ID: 36597305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular study of the hydroxymethylbilane synthase gene (HMBS) among Polish patients with acute intermittent porphyria.
    Gregor A; Schneider-Yin X; Szlendak U; Wettstein A; Lipniacka A; Rüfenacht UB; Minder EI
    Hum Mutat; 2002 Mar; 19(3):310. PubMed ID: 11857754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of age and gender on the clinical expression of acute intermittent porphyria based on molecular study of porphobilinogen deaminase gene among Swiss patients.
    Schuurmans MM; Schneider-Yin X; Rüfenacht UB; Schnyder C; Minder CE; Puy H; Deybach JC; Minder EI
    Mol Med; 2001 Aug; 7(8):535-42. PubMed ID: 11591889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute Intermittent Porphyria: A Report of 3 Cases with Neuropathy.
    Alqwaifly M; Bril V; Dodig D
    Case Rep Neurol; 2019; 11(1):32-36. PubMed ID: 31205461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic strategies for autosomal dominant acute porphyrias: retrospective analysis of 467 unrelated patients referred for mutational analysis of the HMBS, CPOX, or PPOX gene.
    Whatley SD; Mason NG; Woolf JR; Newcombe RG; Elder GH; Badminton MN
    Clin Chem; 2009 Jul; 55(7):1406-14. PubMed ID: 19460837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ALAD Inhibition by Porphobilinogen Rationalizes the Accumulation of δ-Aminolevulinate in Acute Porphyrias.
    San Juan I; Pereira-Ortuzar T; Cendoya X; Laín A; To-Figueras J; Mateos B; Planes FJ; Bernardo-Seisdedos G; Mato JM; Millet O
    Biochemistry; 2022 Nov; 61(21):2409-2416. PubMed ID: 36241173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. De Novo mutation found in the porphobilinogen deaminase gene in Slovak acute intermittent porphyria patient: molecular biochemical study.
    Ulbrichova D; Flachsova E; Hrdinka M; Saligova J; Bazar J; Raman CS; Martasek P
    Physiol Res; 2006; 55 Suppl 2():S145-154. PubMed ID: 17298218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.